Article
Alterations at the cross-bridge level are associated with a paradoxical gain of muscle function in vivo in a mouse model of nemaline myopathy.
PloS one - 1 Jan 2014
Gineste Charlotte, Ottenheijm Coen, Le Fur Yann, Banzet Sébastien, Pecchi Emilie, Vilmen Christophe, Cozzone Patrick J, Koulmann Nathalie, Hardeman Edna C, Bendahan David, Gondin Julien
Abstract excerpt
Nemaline myopathy is the most common disease entity among non-dystrophic skeletal muscle congenital diseases. The first disease causing mutation (Met9Arg) was identified in the gene encoding α-tropomyosin slow gene (TPM3). Considering the conflicting findings of the previous studies on the transgenic (Tg) mice carrying the TPM3Met9Arg mutation, we investigated carefully the effect of the Met9Arg mutation in 8-9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
